BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Synthetic Biologics Announces Management Changes

  Synthetic Biologics announced today that Steve Shallcross, the Company’s CFO, has been named interim CEO to succeed Jeff Riley.

  December 5, 2017

   · 

  4 min read
• Drug Development

  Breakthrough Evidence on Vomaris Bioelectric Technology’s Impact on Wound Biofilm Infection

  Vomaris announced today breakthrough results of the first controlled, preclinical in vivo evidence on the anti-biofilm impact of the Company’s bioelectric antimicrobial technology.

  December 5, 2017

   · 

  5 min read
• 

  Genetown

  Cambridge’s Neon Therapeutics Completes $106M Crossover Series B Funding Round

  The company announced the successful completion of an additional $36 million extension to its Series B financing.

  December 5, 2017

   · 

  2 min read
• Business

  AccuTec Blades Announces Exclusive Australia-New Zealand DermaBlade Agreement

  AccuTec Blades has entered into an agreement with Diplomat Blades to distribute DermaBlade throughout Australia and New Zealand.

  December 5, 2017

   · 

  1 min read
• BioMidwest

  Lilly Initiates Clinical Trial to Evaluate the Functionality and Safety of its Automated Insulin Delivery System

  The AID system is part of the Connected Diabetes Ecosystem, which is being designed to make diabetes management easier by enabling people to use insulin more effectively.

  December 5, 2017

   · 

  4 min read
• Drug Development

  New Scientific Publication Supports Agilvax’s Novel Immunotherapy Development for Metastatic Breast Cancer

  The preclinical results are being published in an article in the journal OncoImmunology, entitled “A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo.”

  December 5, 2017

   · 

  2 min read
• Business

  Medidata Expands Partnership With CytomX Therapeutics to Centralize Management of Regulated and Nonregulated Content

  With the addition of Medidata RCM, CytomX will now manage regulated and nonregulated content in a single, unified platform.

  December 5, 2017

   · 

  2 min read
• Business

  Chembio Receives $8.5M Commitment From Bio-Manguinhos to Purchase Components for Production of DPP Assays in Brazil During 2018

  Chembio received payments of $4.2 million of accounts receivable balances from Bio-Manguinhos.

  December 5, 2017

   · 

  3 min read
• Drug Development

  Mateon Announces Preclinical Data Indicating Enhanced Tumor Immune Response of CA4P With Checkpoint Inhibitor

  Preliminary data suggest immuno-oncology applications for drug candidate.

  December 5, 2017

   · 

  4 min read
• 

  Business

  Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Diseases With Unmet Medical Needs

  Tamid enters exclusive licensing deal with UNC-Chapel Hill for three preclinical gene therapy product candidates.

  December 5, 2017

   · 

  4 min read